View of Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer

Return to Article Details Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer Download Download PDF